Update in Pulmonary Fibrosis: IPF, COVID-19 and Beyond

December 8, 2021

 

 

IMPORTANT BROWSER INFORMATION

This site will not work on Internet Explorer 8. Please use:

Google Chrome      Mozilla FIREFOX   Safari     Opera

                                                                                               

 

The course is a 4-hour virtual conference with five-30 minute presentations on Interstitial Lung Disease and one-hour long panel discussion where challenging cases of ILD are discussed. Concurrently, there will be a patient track lasting 2 hours where common issues pertaining to Pulmonary Fibrosis care is discussed.

 

Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than Saturday, January 22, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Target Audience

This course is designed for physicians, physician assistants, nurse practitioners, and nurses.

Learning Objectives

Following completion of this activity, learners will be able to:

  1. Identify conditions associated with pulmonary fibrosis.
  2. Describe the mechanisms leading to pulmonary fibrosis onset and progression.
  3. Interpret the impact of pulmonary fibrosis on symptoms, pulmonary function, and mortality.
  4. Describe best practices for the early and accurate diagnosis of Interstitial Lung Disease.
  5. Discuss the follow-up of patients with Interstitial Lung Disease.
  6. Evaluate evidence-based strategies and emerging therapies for the pharmacologic and non-pharmacologic treatment of ILD.
  7. Examine the factors and management of pulmonary fibrosis in patients with COVID-19.
Additional information
Jefferson Content Development By: 
Sidney Kimmel Medical College (SKMC)
Thomas Jefferson University Hospital (TJUH)
Content Areas: 
Internal Medicine
Primary Care
Pulmonology
Rheumatology
Course Format: 
Live Webinar
Course summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit
  • 3.75 Attendance
  • 3.75 CNE
  • 3.75 PA
Course opens: 
07/23/2021
Course expires: 
01/22/2022
Event starts: 
12/08/2021 - 1:00pm
Event ends: 
12/08/2021 - 5:00pm
Cost:
$75.00
Rating: 
0

Commercial/In-Kind Support

Any support received for this educational activity will be published and announced prior to the start of the activity.

Agenda subject to change.


Recording and Photography Strictly Prohibited

Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.

image This CE activity is a live virtual meeting. Zoom login information will be provided to registrants prior to the start of the activity.

 

 

 

Conflict of Interest

Thomas Jefferson University endorses the ACCME Standards for Commercial Support: Standards to Ensure Independence in CME Activities and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any relevant financial relationships with ACCME defined commercial interest entities within the past 12 months. Any conflict of interests have been mitigated prior to the educational activity.

Such disclosures will be available prior to the start of the activity. ​Jefferson Conflict of Interest resolution process may result in changes to the program agenda.

Planning Committee

Gautam George, MD-Activity Director
Ross Summer, MD
Marisa Hutcheon, BSN, RN
Katherine Stull, PA

Presenters

Gautam George, MD
Ross Summer, MD
Marisa Hutcheon, RN
Tamra Parez, RN
Katherine Stull, PA
Jesse Roman, MD
Daniel Kramer, MD
Rafael Parez, MD
Baskaran Sundaram, MD
Jeffrey Baliff, MD
Giorgos Loizidis, MD

Off‐label/Investigational Use

All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
 

 

Accreditation

https://jointaccreditation.org/sites/default/files/JointlyAccreditedProviderTM_0.pngIn support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation

Physicians: This educational activity is designated for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 3.75 nursing contact hours.

Physician Assistants:

Thomas Jefferson University has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with  the extent of their participation.
 

Other Healthcare Professionals: This educational activity is designated for 3.75 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit

This educational activity offers 1.0 nursing pharmacology credit.

Available Credit

  • 3.75 AMA PRA Category 1 Credit
  • 3.75 Attendance
  • 3.75 CNE
  • 3.75 PA

To exhibit at this virtual activity, please contact Marie Destin, MBA.

Price

Cost:
$75.00
Please login or register to take this course.

Registration Information

IMPORTANT DEADLINES

  • Pre-registration ends 09/8/2021 at 1:00 PM EST
  • No refunds will be granted after 08/27/2021. See full refund policy

To register online, you must have a CPD @ JeffLearn account.

  1. Log in or create an account. - Note: This website will not work on Internet Explorer 8. 
  2. Review the chart below and select the registration fee that best fits. Final price will be reflected when you check out. You must be logged in to see the "Add to Cart" function.
  3. Check out and pay with Visa, MasterCard or American Express.

RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED

Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.